Cardiovascular Systems, Inc.
CSII · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $540 | $549 | $565 | $888 |
| - Cash | $60 | $63 | $66 | $67 |
| + Debt | $20 | $21 | $20 | $20 |
| Enterprise Value | $500 | $508 | $519 | $841 |
| Revenue | $61 | $60 | $62 | $56 |
| % Growth | 3% | -4.5% | 11.2% | – |
| Gross Profit | $43 | $43 | $46 | $41 |
| % Margin | 70% | 72% | 74% | 73.7% |
| EBITDA | -$7 | -$9 | -$9 | -$9 |
| % Margin | -11.5% | -15.1% | -14.2% | -15.7% |
| Net Income | -$8 | -$11 | -$10 | -$10 |
| % Margin | -12.8% | -17.8% | -15.5% | -17.2% |
| EPS Diluted | -0.2 | -0.27 | -0.25 | -0.25 |
| % Growth | 25.9% | -8% | 0% | – |
| Operating Cash Flow | -$4 | -$14 | -$10 | -$2 |
| Capital Expenditures | -$2 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$6 | -$14 | -$11 | -$3 |